{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T13:06:35Z","timestamp":1770728795938,"version":"3.49.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Radiation Oncology"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.semradonc.2023.01.005","type":"journal-article","created":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T10:24:20Z","timestamp":1679912660000},"page":"129-138","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Brain Metastases: Is There Still a Role for Whole-Brain Radiation Therapy?"],"prefix":"10.1016","volume":"33","author":[{"given":"Carsten","family":"Nieder","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolaus H.","family":"Andratschke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anca L.","family":"Grosu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.semradonc.2023.01.005_bib0001","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1200\/JCO.21.01715","article-title":"Managing central nervous system spread of lung cancer: The state of the art","volume":"40","author":"Tsui","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semradonc.2023.01.005_bib0002","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.lungcan.2021.10.016","article-title":"Prophylactic cranial irradiation (PCI), hippocampal avoidance (HA) whole brain radiotherapy (WBRT) and stereotactic radiosurgery (SRS) in small cell lung cancer (SCLC): Where do we stand?","volume":"162","author":"Crockett","year":"2021","journal-title":"Lung Cancer"},{"key":"10.1016\/j.semradonc.2023.01.005_bib0003","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1002\/cncr.25707","article-title":"Presentation, patterns of care, and survival in patients with brain metastases: what has changed in the last 20 years?","volume":"117","author":"Nieder","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.semradonc.2023.01.005_bib0004","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/1748-717X-9-155","article-title":"Stereotactic radiosurgery (SRS) for brain metastases: A systematic review","volume":"9","author":"Nieder","year":"2014","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.semradonc.2023.01.005_bib0005","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1148\/91.1.149","article-title":"Improvement in quality of survival following whole-brain irradiation for brain metastasis","volume":"91","author":"Order","year":"1968","journal-title":"Radiology"},{"key":"10.1016\/j.semradonc.2023.01.005_bib0006","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/0360-3016(81)90005-5","article-title":"The palliation of brain metastases in a favorable patient population: A randomized clinical trial by the Radiation Therapy Oncology Group","volume":"7","author":"Kurtz","year":"1981","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2023.01.005_bib0007","article-title":"Whole brain radiotherapy for the treatment of newly diagnosed multiple brain metastases","volume":"1","author":"Tsao","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.semradonc.2023.01.005_bib0008","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1159\/000513975","article-title":"Recursive partitioning analysis of systemic therapy after radiotherapy in patients with brain metastases","volume":"44","author":"Nieder","year":"2021","journal-title":"Oncol Res Treat"},{"key":"10.1016\/j.semradonc.2023.01.005_bib0009","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1007\/s00432-022-03919-0","article-title":"Primary systemic therapy for patients with brain metastases from lung cancer ineligible for targeted agents","volume":"148","author":"Nieder","year":"2022","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.semradonc.2023.01.005_bib0010","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1001\/jamaoncol.2016.5414","article-title":"The changing role of whole-brain radiotherapy: Demise or time for selective usage?","volume":"3","author":"Mehta","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.semradonc.2023.01.005_bib0011","doi-asserted-by":"crossref","first-page":"3776","DOI":"10.1002\/cncr.32375","article-title":"The impact of targeted therapies and immunotherapy in melanoma brain metastases: A systematic review and meta-analysis","volume":"125","author":"Rulli","year":"2019","journal-title":"Cancer"},{"key":"10.1016\/j.semradonc.2023.01.005_bib0012","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0360-3016(97)00154-5","article-title":"Tumor-related prognostic factors for remission of brain metastases after radiotherapy","volume":"39","author":"Nieder","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2023.01.005_bib0013","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1200\/JCO.2003.12.122","article-title":"Survival and neurologic outcomes in a randomized trial of motexafin gadolinium and whole-brain radiation therapy in brain metastases","volume":"21","author":"Mehta","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semradonc.2023.01.005_bib0014","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1200\/JCO.2004.05.128","article-title":"Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: Results of a randomized phase III trial","volume":"22","author":"Meyers","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semradonc.2023.01.005_bib0015","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.ijrobp.2009.05.032","article-title":"Randomized comparison of whole brain radiotherapy, 20 Gy in four daily fractions versus 40 Gy in 20 twice-daily fractions, for brain metastases","volume":"77","author":"Graham","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2023.01.005_bib0016","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jpainsymman.2005.02.009","article-title":"Prospective assessment of patient-rated symptoms following whole brain radiotherapy for brain metastases","volume":"30","author":"Chow","year":"2005","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.semradonc.2023.01.005_bib0017","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1200\/JCO.19.01414","article-title":"Adjuvant whole-brain radiation therapy compared with observation after local treatment of melanoma brain metastases: A multicenter, randomized phase III trial","volume":"37","author":"Hong","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semradonc.2023.01.005_bib0018","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1093\/neuonc\/noaa281","article-title":"Whole-brain radiotherapy with and without concurrent erlotinib in NSCLC with brain metastases: A multicenter, open-label, randomized, controlled phase III trial","volume":"23","author":"Yang","year":"2021","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.semradonc.2023.01.005_bib0019","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S1470-2045(09)70263-3","article-title":"Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: A randomised controlled trial","volume":"10","author":"Chang","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.semradonc.2023.01.005_bib0020","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1097\/00000421-199912000-00007","article-title":"Late radiation toxicity after whole brain radiotherapy: The influence of antiepileptic drugs","volume":"22","author":"Nieder","year":"1999","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.semradonc.2023.01.005_bib0021","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ijrobp.2019.10.024","article-title":"Optimizing whole brain radiation therapy dose and fractionation: Results from a prospective phase 3 trial (NCCTG N107C [Alliance]\/CEC.3)","volume":"106","author":"Trifiletti","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2023.01.005_bib0022","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.ijrobp.2007.05.038","article-title":"Whole brain radiotherapy with hippocampal avoidance and simultaneously integrated brain metastases boost: A planning study","volume":"69","author":"Guti\u00e9rrez","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2023.01.005_bib0023","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1002\/cncr.32787","article-title":"Hippocampus-avoidance whole-brain radiation therapy with a simultaneous integrated boost for multiple brain metastases","volume":"126","author":"Popp","year":"2020","journal-title":"Cancer"},{"key":"10.1016\/j.semradonc.2023.01.005_bib0024","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.ijrobp.2010.01.039","article-title":"Hippocampal-sparing whole-brain radiotherapy: A \"how-to\" technique using helical tomotherapy and linear accelerator-based intensity-modulated radiotherapy","volume":"78","author":"Gondi","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2023.01.005_bib0025","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.714709","article-title":"Hippocampus-avoidance whole-brain radiation therapy is efficient in the long-term preservation of hippocampal volume","volume":"11","author":"Popp","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.semradonc.2023.01.005_bib0026","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1200\/JCO.19.02767","article-title":"Hippocampal avoidance during whole-brain radiotherapy plus memantine for patients with brain metastases: Phase III trial NRG Oncology CC001","volume":"38","author":"Brown","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semradonc.2023.01.005_bib0027","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/ddrr.26","article-title":"Cranial radiation therapy and damage to hippocampal neurogenesis","volume":"14","author":"Monje","year":"2008","journal-title":"Dev Disabil Res Rev"},{"key":"10.1016\/j.semradonc.2023.01.005_bib0028","doi-asserted-by":"crossref","first-page":"255","DOI":"10.2307\/3578619","article-title":"Gamma radiation (5-10 Gy) impairs neuronal function in the guinea pig hippocampus","volume":"136","author":"Pellmar","year":"1993","journal-title":"Radiat Res"},{"key":"10.1016\/j.semradonc.2023.01.005_bib0029","doi-asserted-by":"crossref","first-page":"3810","DOI":"10.1200\/JCO.2014.57.2909","article-title":"Preservation of memory with conformal avoidance of the hippocampal neural stem-cell compartment during whole-brain radiotherapy for brain metastases (RTOG 0933): A phase II multi-institutional trial","volume":"32","author":"Gondi","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semradonc.2023.01.005_bib0030","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1093\/neuonc\/not114","article-title":"Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: A randomized, double-blind, placebo-controlled trial","volume":"15","author":"Brown","year":"2013","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.semradonc.2023.01.005_bib0031","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1186\/s12885-020-07011-z","article-title":"Whole-brain irradiation with hippocampal sparing and dose escalation on metastases: neurocognitive testing and biological imaging (HIPPORAD) - a phase II prospective randomized multicenter trial (NOA-14, ARO 2015-3, DKTK-ROG)","volume":"20","author":"Grosu","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.semradonc.2023.01.005_bib0032","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s00066-022-01916-3","article-title":"Optimization of hippocampus sparing during whole brain radiation therapy with simultaneous integrated boost\u2014tutorial and efficacy of complete directional hippocampal blocking","volume":"198","author":"Popp","year":"2022","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.semradonc.2023.01.005_bib0033","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1001\/jama.280.17.1485","article-title":"Postoperative radiotherapy in the treatment of single metastases to the brain: A randomized trial","volume":"280","author":"Patchell","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.semradonc.2023.01.005_bib0034","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/S1470-2045(17)30414-X","article-title":"Post-operative stereotactic radiosurgery versus observation for completely resected brain metastases: A single-centre, randomised, controlled, phase 3 trial","volume":"18","author":"Mahajan","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.semradonc.2023.01.005_bib0035","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S1470-2045(17)30441-2","article-title":"Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C\/CEC\u00b73): A multicentre, randomised, controlled, phase 3 trial","volume":"18","author":"Brown","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.semradonc.2023.01.005_bib0036","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1200\/JCO.2010.30.1655","article-title":"Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: Results of the EORTC 22952-26001 study","volume":"29","author":"Kocher","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semradonc.2023.01.005_bib0037","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.radonc.2014.07.007","article-title":"Patterns of distant brain recurrences after radiosurgery alone for newly diagnosed brain metastases: Implications for salvage therapy","volume":"112","author":"Zindler","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.semradonc.2023.01.005_bib0038","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1093\/neuonc\/noaa298","article-title":"Prognostic validation and clinical implications of the EANO ESMO classification of leptomeningeal metastasis from solid tumors","volume":"23","author":"Le Rhun","year":"2021","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.semradonc.2023.01.005_bib0039","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s00066-022-01910-9","article-title":"Whole brain radiotherapy combined with intrathecal liposomal cytarabine for leptomeningeal metastasis-a safety analysis and validation of the EANO-ESMO classification","volume":"198","author":"Iglseder","year":"2022","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.semradonc.2023.01.005_bib0040","first-page":"vdab162","article-title":"Leptomeningeal disease in neurosurgical brain metastases patients: A systematic review and meta-analysis","volume":"3","author":"Tewarie","year":"2021","journal-title":"Neurooncol Adv"},{"key":"10.1016\/j.semradonc.2023.01.005_bib0041","first-page":"vdab036","article-title":"Outcome comparison of patients who develop leptomeningeal disease or distant brain recurrence after brain metastases resection cavity radiosurgery","volume":"3","author":"Teyateeti","year":"2021","journal-title":"Neurooncol Adv"},{"key":"10.1016\/j.semradonc.2023.01.005_bib0042","article-title":"Leptomeningeal disease and neurologic death after surgical resection and radiosurgery for brain metastases: A multi-institutional analysis","volume":"6","author":"Prabhu","year":"2021","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.semradonc.2023.01.005_bib0043","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1200\/JCO.21.02314","article-title":"Treatment for brain metastases: ASCO-SNO-ASTRO guideline","volume":"40","author":"Vogelbaum","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semradonc.2023.01.005_bib0044","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1200\/JCO.20.01255","article-title":"Survival in patients with brain metastases: Summary report on the updated diagnosis-specific graded prognostic assessment and definition of the eligibility quotient","volume":"38","author":"Sperduto","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semradonc.2023.01.005_bib0045","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ijrobp.2022.03.020","volume":"114","author":"Sperduto","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2023.01.005_bib0046","first-page":"1255","article-title":"Combining standard clinical blood values for improving survival prediction in patients with newly diagnosed brain metastases-development and validation of the LabBM score","volume":"19","author":"Berghoff","year":"2017","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.semradonc.2023.01.005_bib0047","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.21873\/anticanres.14189","article-title":"Remaining lifespan of patients aged \u226565 years receiving whole-brain irradiation for metastases from cancer of unknown primary","volume":"40","author":"Rades","year":"2020","journal-title":"Anticancer Res"},{"key":"10.1016\/j.semradonc.2023.01.005_bib0048","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00408-019-00223-6","article-title":"A new diagnosis-specific survival score for patients to be irradiated for brain metastases from non\u2013small cell lung cancer","volume":"197","author":"Rades","year":"2019","journal-title":"Lung"},{"key":"10.1016\/j.semradonc.2023.01.005_bib0049","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0360-3016(96)00619-0","article-title":"Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials","volume":"37","author":"Gaspar","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2023.01.005_bib0050","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.radonc.2022.04.024","article-title":"Comprehensive summary and retrospective evaluation of prognostic scores for patients with newly diagnosed brain metastases treated with upfront radiosurgery in a modern patient collective","volume":"172","author":"Kraft","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.semradonc.2023.01.005_bib0051","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13014-019-1237-9","article-title":"Management of patients with brain metastases from non\u2013small cell lung cancer and adverse prognostic features: Multi-national radiation treatment recommendations are heterogeneous","volume":"14","author":"Nieder","year":"2019","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.semradonc.2023.01.005_bib0052","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s10585-013-9573-x","article-title":"Radiotherapy versus best supportive care in patients with brain metastases and adverse prognostic factors","volume":"30","author":"Nieder","year":"2013","journal-title":"Clin Exp Metastasis"},{"key":"10.1016\/j.semradonc.2023.01.005_bib0053","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1016\/S0140-6736(16)30825-X","volume":"388","author":"Mulvenna","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.semradonc.2023.01.005_bib0054","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.prro.2022.02.003","article-title":"Radiation therapy for brain metastases: An ASTRO clinical practice guideline","volume":"12","author":"Gondi","year":"2022","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.semradonc.2023.01.005_bib0055","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1200\/JCO.2011.38.0527","article-title":"Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases","volume":"30","author":"Sperduto","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semradonc.2023.01.005_bib0056","doi-asserted-by":"crossref","first-page":"977","DOI":"10.21873\/anticanres.14031","article-title":"Confirmatory analysis of QUARTZ study results: Survival prolongation after whole-brain radiotherapy","volume":"40","author":"Nieder","year":"2020","journal-title":"Anticancer Res"},{"key":"10.1016\/j.semradonc.2023.01.005_bib0057","first-page":"2671","article-title":"Best supportive care in patients with brain metastases and adverse prognostic factors: Development of improved decision aids","volume":"21","author":"Nieder","year":"2013","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.semradonc.2023.01.005_bib0058","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1007\/s00066-013-0442-y","article-title":"Brain metastasis. Prognostic value of the number of involved extracranial organs","volume":"189","author":"Rades","year":"2013","journal-title":"Strahlenther Onkol"}],"container-title":["Seminars in Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105342962300005X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105342962300005X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T08:52:11Z","timestamp":1760950331000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S105342962300005X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":58,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S105342962300005X"],"URL":"https:\/\/doi.org\/10.1016\/j.semradonc.2023.01.005","relation":{},"ISSN":["1053-4296"],"issn-type":[{"value":"1053-4296","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Brain Metastases: Is There Still a Role for Whole-Brain Radiation Therapy?","name":"articletitle","label":"Article Title"},{"value":"Seminars in Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semradonc.2023.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}